Transaction DateRecipientSharesTypePriceValue
Pulmatrix logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 8/10.

Pulmatrix is a clinical stage biotechnology company. The firm focuses on the prevention and treatment of respiratory diseases and infections. It offers products based on its proprietary dry powder delivery technology, iSPERSE.

Ticker: PULM
Sector: Healthcare
Industry: Biotechnology
SEC Central Index Key (CIK): 1574235
Employees: 22
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags